These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 6703263)
21. Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. Fjellner B; Hägermark O Acta Derm Venereol; 1985; 65(5):409-12. PubMed ID: 2416164 [TBL] [Abstract][Full Text] [Related]
22. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists. Coëffier E; Joseph D; Vargaftig BB J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895 [TBL] [Abstract][Full Text] [Related]
23. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. Lellouch-Tubiana A; Lefort J; Simon MT; Pfister A; Vargaftig BB Am Rev Respir Dis; 1988 Apr; 137(4):948-54. PubMed ID: 3281530 [TBL] [Abstract][Full Text] [Related]
24. Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets. Ostermann G; Till U; Thielmann K Thromb Res; 1984 Feb; 33(4):409-18. PubMed ID: 6710440 [TBL] [Abstract][Full Text] [Related]
25. Synergism between platelet-activating factor (PAF-acether) and prostaglandin E2 in man. McGivern DV; Basran GS Eur J Pharmacol; 1984 Jun; 102(1):183-5. PubMed ID: 6592097 [TBL] [Abstract][Full Text] [Related]
26. Inflammatory characteristics of PAF-acether in the skin of experimental animals and man. Archer CB; Page CP; Paul W; Morley J; MacDonald DM Int J Tissue React; 1985; 7(5):363-5. PubMed ID: 3863807 [TBL] [Abstract][Full Text] [Related]
27. Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin. Morley J; Page CP; Paul W Br J Pharmacol; 1983 Nov; 80(3):503-9. PubMed ID: 6685552 [TBL] [Abstract][Full Text] [Related]
28. PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils. Pirotzky E; Page CP; Roubin R; Pfister A; Paul W; Bonnet J; Benveniste J Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):107-22. PubMed ID: 6546141 [TBL] [Abstract][Full Text] [Related]
29. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation. Coëffier E; Delautier D; Le Couedic JP; Chignard M; Denizot Y; Benveniste J J Leukoc Biol; 1990 Mar; 47(3):234-43. PubMed ID: 2307906 [TBL] [Abstract][Full Text] [Related]
30. Influence of prostaglandins and PG-analogues on the mortality of PAF-acether in mice and the TXB2 release from human granulocytes. Becker K; Förster W Biomed Biochim Acta; 1988; 47(10-11):S169-72. PubMed ID: 3248104 [TBL] [Abstract][Full Text] [Related]
31. Increase in the rat blood leukocyte counts induced by PAF-acether is suppressed by general anesthesia. Bozza PT; Silva PM; Castro-Faria-Neto HC; Martins MA; Cordeiro RS J Leukoc Biol; 1992 Feb; 51(2):146-50. PubMed ID: 1431550 [TBL] [Abstract][Full Text] [Related]
32. Platelet-activating factor nasal challenge induces nasal congestion and reduces nasal volume in both healthy volunteers and allergic rhinitis patients. Muñoz-Cano R; Valero A; Roca-Ferrer J; Bartra J; Sanchez-Lopez J; Mullol J; Picado C Am J Rhinol Allergy; 2013; 27(2):e48-52. PubMed ID: 23562190 [TBL] [Abstract][Full Text] [Related]
33. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances. Vargaftig BB; Joseph D; Marlas G; Chevance LG Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345 [TBL] [Abstract][Full Text] [Related]
34. The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes. Sperling RI; Robin JL; Kylander KA; Lee TH; Lewis RA; Austen KF J Immunol; 1987 Dec; 139(12):4186-91. PubMed ID: 2826583 [TBL] [Abstract][Full Text] [Related]
35. Characteristics of the binding of platelet-activating factor to platelets of different animal species. Iñarrea P; Gomez-Cambronero J; Nieto M; Crespo MS Eur J Pharmacol; 1984 Oct; 105(3-4):309-15. PubMed ID: 6510472 [TBL] [Abstract][Full Text] [Related]
36. Platelet-activating factor-acether-induced relaxation of guinea pig airway muscle: role of prostaglandin E2 and the epithelium. Brunelleschi S; Haye-Legrand I; Labat C; Norel X; Benveniste J; Brink C J Pharmacol Exp Ther; 1987 Oct; 243(1):356-63. PubMed ID: 3478474 [TBL] [Abstract][Full Text] [Related]
37. Synthesis of platelet-activating factor from human polymorphonuclear leukocytes: regulation and pharmacological approaches. Sánchez Crespo M; Alonso F; García Gil M; Gómez-Cambronero J; Nieto ML Int J Tissue React; 1985; 7(5):345-9. PubMed ID: 2997066 [TBL] [Abstract][Full Text] [Related]
38. Immunoregulatory functions of paf-acether. I. Effect of paf-acether on CD4+ cell proliferation. Dulioust A; Vivier E; Salem P; Benveniste J; Thomas Y J Immunol; 1988 Jan; 140(1):240-5. PubMed ID: 2961808 [TBL] [Abstract][Full Text] [Related]
39. Immunoregulatory functions of paf-acether. II. Decrease of CD2 and CD3 antigen expression. Vivier E; Salem P; Dulioust A; Praseuth D; Metezeau P; Benveniste J; Thomas Y Eur J Immunol; 1988 Mar; 18(3):425-30. PubMed ID: 2895712 [TBL] [Abstract][Full Text] [Related]
40. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release. Touqui L; Herpin-Richard N; Gene RM; Jullian E; Aljabi D; Hamberger C; Vargaftig BB; Dessange JF J Allergy Clin Immunol; 1994 Jul; 94(1):109-19. PubMed ID: 8027488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]